References
- Stewart PM. The adrenal cortex. In: Kronenberg HM, Melmed S, Polonsky KS, Larsen PR, eds. Williams Textbook of Endocrinology, 11th edn. Philadelphia: Saunders, 2008. 460–77.
- Hopkins RL, Leinung MC. Exogenous Cushing’s syndrome and glucocorticoid with drawl. Endocrinol Metabol Clin North Am 2005; 34:371–84.
- Findlay CA, Macdonald JF, Wallace AM, Geddes N, Donaldson MDC. Childhood Cushing’s syndrome induced by betamethasone nose drops, and repeat prescriptions. Br Med J 1998; 317:739–40.
- Carpio A. Neurocysticercosis: an update. Lancet Infect Dis 2002; 2:751–62.
- Igaz P, Racz K, Toth M, Glaz E, Tulassay Z. Treatment of iatrogenic Cushing syndrome: questions of glucocorticoid withdrawal. Orv Hetil 2007; 148:195–202.
- White PC. Adrenocortical insufficiency. In: Kliegman RM, Behrman RE, Jenson HB, Stanton BF, eds. Nelson Textbook of Pediatrics, 18th edn. Philadelphia: Saunders, 2007; 2359.
- Teelucksingh S, Balkaran B, Ganeshmoorthi A, Arthur P. Prolonged childhood Cushing’s syndrome secondary to intralesional triamcinolone acetonide. Ann Trop Paediatr 2002; 22:89–91.
- Ramanathan R, Pau AK, Busse KH, et al. Iatrogenic Cushing syndrome after epidural triamcinolone injections in an HIV type 1 -infected patient receiving therapy with ritonavir-lopinavir. Clin Infect Dis 2008; 47: e97–9.
- Yombi JC, Maiter D, Belkhir L, Nzeusseu A, Vandercam B. Iatrogenic Cushing’s syndrome and secondary adrenal insufficiency after a single intra- articular administration of triamcinolone acetonide in HIV-infected patients treated with ritonavir. Clin Rheumatol 2008; 27 (suppl. 2):S79–82.
- Dupont C, Giraud V, Leporrier J, Greffe S, Rouveix E, Chinet T. Cushing’s syndrome induced by combined treatment with inhaled fluticasone and oral ritonavir. Rev Mal Respir 2009; 26:779–82.
- Valin N, de Castro N, Garrait V, Bergeron A, Bouche C, Molina JM. Iatrogenic Cushing’s syndrome in HIV-infected patients receiving ritonavir and inhaled fluticasone: description of 4 new cases and review of the literature. J Int Assoc Physicians AIDS Care 2009; 8:113–21.
- Bouldouyre MA, Moachon L, Guillevin L, Launay O. Iatrogenic Cushing syndrome in an HIV-infected female patient: be careful about interaction inhaled corticosteroids – ritonavir! Presse Med 2008; 37:1834–5.
- Foisy MM, Yakiwchuk EM, Chiu I, Singh AE. Adrenal suppression and Cushing’s syndrome secondary to an interaction between ritonavir and fluticasone: a review of the literature. HIV Med 2008; 9:389–96.
- Semiz S, Balci YI, Ergin S, Candemir M, Polat A. Two cases of Cushing’s syndrome due to overuse of topical steroid in the diaper area. Pediatr Dermatol 2008; 25:544–7.
- Azizi F, Jahed A, Hedayati M, et al. Outbreak of exogenous Cushing’s syndrome due to unlicensed medications. Clin Endocrinol (Oxf) 2008; 69:921–5.